AGL vs. PINC, PGNY, SHC, AMPH, RXRX, DNA, DCPH, AMRX, NEO, and KROS
Should you be buying agilon health stock or one of its competitors? The main competitors of agilon health include Premier (PINC), Progyny (PGNY), Sotera Health (SHC), Amphastar Pharmaceuticals (AMPH), Recursion Pharmaceuticals (RXRX), Ginkgo Bioworks (DNA), Deciphera Pharmaceuticals (DCPH), Amneal Pharmaceuticals (AMRX), NeoGenomics (NEO), and Keros Therapeutics (KROS). These companies are all part of the "medical" sector.
agilon health (NYSE:AGL) and Premier (NASDAQ:PINC) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking and earnings.
Premier has lower revenue, but higher earnings than agilon health. agilon health is trading at a lower price-to-earnings ratio than Premier, indicating that it is currently the more affordable of the two stocks.
agilon health presently has a consensus target price of $9.32, indicating a potential upside of 72.14%. Premier has a consensus target price of $23.50, indicating a potential upside of 19.53%. Given agilon health's stronger consensus rating and higher probable upside, analysts plainly believe agilon health is more favorable than Premier.
agilon health has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, Premier has a beta of 0.39, meaning that its stock price is 61% less volatile than the S&P 500.
Premier has a net margin of 6.01% compared to agilon health's net margin of -5.67%. Premier's return on equity of 11.71% beat agilon health's return on equity.
74.4% of Premier shares are owned by institutional investors. 3.2% of agilon health shares are owned by company insiders. Comparatively, 0.9% of Premier shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
In the previous week, agilon health had 10 more articles in the media than Premier. MarketBeat recorded 19 mentions for agilon health and 9 mentions for Premier. Premier's average media sentiment score of 0.42 beat agilon health's score of 0.12 indicating that Premier is being referred to more favorably in the news media.
Premier received 563 more outperform votes than agilon health when rated by MarketBeat users. Likewise, 69.07% of users gave Premier an outperform vote while only 52.69% of users gave agilon health an outperform vote.
Summary
Premier beats agilon health on 11 of the 18 factors compared between the two stocks.
Get agilon health News Delivered to You Automatically
Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
agilon health Competitors List
Related Companies and Tools
